The rollback of funding for anti-malaria efforts in the Mekong is just one of many examples of cuts that are raising alarm ...

The PETITE study is evaluating two formulations of dolutegravir in newborn babies under 4 weeks of age – an oral film. In the ...

The cancellation of USAID contracts has threatened critical global health research. Plus, new guidance to prevent HIV in ...

Thailand is working with authorities in the capital cities or embassies of some countries that have citizens stuck on the ...

Founded 5 years ago, the Institute of HIV Research and Innovation works with communities to answer the research questions that matter most to them. Sima Barmania reports from Bangkok.

Adolescents who are treatment-naive had promising results when using dolutegravir/lamivudine as antiretroviral therapy over 48 weeks.

U=U is short for Undetectable = Untransmittable. It means that when a person living with HIV, adheres to effective ...

The PETITE-DTG study evaluated dolutegravir (DTG) — a drug that revolutionized HIV treatment in adults and children — in ...

A new study sheds light on how to halve the number of new HIV infections among men who have sex with men in Bangkok. Thailand has been hit hard by HIV. 440,000 people are living with HIV in Thailand ...

Nearly half (44%) of all new HIV infections globally in 2023 were in women and girls.1 Adolescent girls and young women are disproportionately affected by HIV, particularly in sub-Saharan Africa where ...

Police are known to have traditionally closed an eye to the city’s sex trade and its fringe activities but are now tightening ...